---
created: 2025-04-13
updated: 2025-04-13T10:52
id: N1d|?oCw4c
specialty: neuro
specialty_id: 151
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::19-mixed-agonist-&-antagonist-opioid-analgesics
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::19-mixed-agonist-&-antagonist-opioid-analgesics::buprenorphine
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::19-mixed-agonist-&-antagonist-opioid-analgesics::butorphanol
  - "source/ak-step1-v11:": 
  - theme/firstaid::13-psychiatry::03-pharm::14-opioid-detoxification-&-relapse-prevention
  - "source/ak-step1-v11:": 
  - theme/firstaid::13-psychiatry::03-pharm::14-opioid-detoxification-&-relapse-prevention::buprenorphine
  - "source/ak-step1-v11:": 
  - theme/firstaid::13-psychiatry::03-pharm::14-opioid-detoxification-&-relapse-prevention::butorphanol
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::12-psychiatry
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::13-psychiatric::30-opioid-withdrawal,-detoxification-and-relapse-prevention
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::14-neuro::21-opioid-clinical-use,-mechanism-and-overdose
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::14-neuro::22-mixed-agonist-and-antagonist-opioids-(nalbuphine-pentazocine-butorphanol)
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::15-other-neuro::full-opioid-agonists
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::15-other-neuro::partial-opioid-agonists
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::06-neuro/psych::02-anesthetics-&-analgesics::03-opiates,-naloxone,-naltrexone
  - source/ak-step1-v11::$ankingupdates::$errata::v06
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - "source/ak-step2-v11:": 
  - theme/b&b::03-psych::03-substance-abuse::02-substance-abuse-i"
type: flashcard
---

# Question
Buprenorphine, and butorphanol are μ-opioid **partial agonists**

---

# Answer
"""bu-phin"" sound in names; exception: pentazocine and nalbuphine (κ-opioid receptor agonists and weak μ-opioid receptor antagonists or partial agonists)   Butorphanol is also a κ-opioid receptor agonist"